![Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia | Arteriosclerosis, Thrombosis, and Vascular Biology Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/e1cc1476-6d41-49c7-ad45-d785887ab9a2/atvbaha.120.315175.fig05.jpg)
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia | Arteriosclerosis, Thrombosis, and Vascular Biology
![PDF) The Extent Application of Management Accounting Techniques, Case Study: Five Star Hotels in Jordan PDF) The Extent Application of Management Accounting Techniques, Case Study: Five Star Hotels in Jordan](https://i1.rgstatic.net/publication/318652719_The_Extent_Application_of_Management_Accounting_Techniques_Case_Study_Five_Star_Hotels_in_Jordan/links/5bb4759e45851574f7f7518f/largepreview.png)
PDF) The Extent Application of Management Accounting Techniques, Case Study: Five Star Hotels in Jordan
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
![Antoine ABOU FAYAD | Assistant Professor | PhD in Bioorganic Chemistry | American University of Beirut, Beirut | AUB | Department of Experimental Pathology, Microbiology, and Immunology | Research profile Antoine ABOU FAYAD | Assistant Professor | PhD in Bioorganic Chemistry | American University of Beirut, Beirut | AUB | Department of Experimental Pathology, Microbiology, and Immunology | Research profile](https://i1.rgstatic.net/ii/profile.image/902987673247744-1592300446682_Q512/Antoine-Abou-Fayad.jpg)
Antoine ABOU FAYAD | Assistant Professor | PhD in Bioorganic Chemistry | American University of Beirut, Beirut | AUB | Department of Experimental Pathology, Microbiology, and Immunology | Research profile
![Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/f15b7c82-70db-4f33-b149-37c261703c9a/gr1.gif)
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
![Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet](https://www.thelancet.com/cms/attachment/03197da1-e15f-4d52-bfd5-a54f3ccf9cec/gr1.gif)